연세-유일한 폐암 연구소는
폐암 완치를 위한
신약을 연구하고 있습니다
연세-유일한 폐암 연구소는
-
공지
2022-03-23Antitumor efficacy of repotrectinib in ROS1+PDC-dr…
Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib...
-
공지
2022-03-16Antitumor efficacy of repotrectinib in ROS1+PDC-dr…
Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrectinib...
-
공지
2022-03-16Antitumor efficacy of repotrectinib in ROS1+PDC-dr…
Antitumor efficacy of repotrectinib in ROS1+PDC-driven Antitumor Antitumor efficacy of repotrec...